ロード中...
A Canadian perspective on bendamustine for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma
Despite the success of standard treatments in chronic lymphocytic leukemia (cll) and non-Hodgkin lymphoma (nhl), patients are often unable to tolerate aggressive regimens, and they require effective alternatives. Bendamustine is a bifunctional alkylator with unique properties that significantly dist...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Multimed Inc.
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3364766/ https://ncbi.nlm.nih.gov/pubmed/22670095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.19.1064 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|